PharmaCyte Biotech Inc. (PMCB) Live Share Price, Invest From India

PharmaCyte Biotech Inc. Stock Performance

as on June 18, 2026 at 6:58 am IST

Day's High
$0.78
Day's Price Range
$0.82
$0.78
5.13%
Upside
52 Week's Low
52 Week's High
$0.63
52-Week Price Range
$1.51
$0.78
19.23%
Downside
93.59%
Upside

PharmaCyte Biotech Inc. share price movements today

Previous Close: $0.83
Open: $0.79
Volume: 669.1K
Day's Low - High: $0.78 - $0.82
52 Week Low - High: $0.63 - $1.51

PharmaCyte Biotech Inc. Historical Returns

1 Month Return: + 2.93 %
3 Month Return: + 20 %
1 Year Return: -21.89 %
3 Year Return: -72.85 %
5 Year Return: 0 %

PharmaCyte Biotech Inc. Stock Fundamentals & Key Indicators

Check PharmaCyte Biotech Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.7M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-8.24%

PharmaCyte Biotech Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PharmaCyte Biotech Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
PharmaCyte Biotech Inc.	SELL	$8.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.4B	63.66%	72.49	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.3B	140.59%	26.73	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.5B	14.69%	15.02	29.65%	0.58%

Stock Returns calculator for PharmaCyte Biotech Inc. Stock including INR - Dollar returns

The PharmaCyte Biotech Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

PharmaCyte Biotech Inc. investment value today

Current value as on today

₹80,560

Returns

-₹19,440

(-19.44%)

Returns from PharmaCyte Biotech Inc. Stock

-₹26,415 (-26.42%)

Dollar Impact

₹6,976 (+6.98%)

Analyst Recommendation on PharmaCyte Biotech Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Indian Investors' Interest in PharmaCyte Biotech Inc. Stock

Search interest for PharmaCyte Biotech Inc. Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 19, 2026 to June 18, 2026

Change:-28% versus previous 30 day period

PharmaCyte Biotech Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-1	-1	-1	-1	-1	0	-1	0	-1	-2
EBITDA	-1	-1	-	1	-1	0	-	-8	-1	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	2	0	1	23	-1	-3	11	-8	-7	0
Income Tax Expense	0	0	-	1	-	-	-	-	-	-
Net Income	2	0	1	23	-1	-3	11	-8	-7	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

PharmaCyte Biotech Inc. Annual Profit & Loss

All numbers in Millions USD

	Apr 2016	Apr 2017	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-6	-4	-6	-4	-3	-3	-4	-6	-6	-4
EBITDA	-6	-4	-6	-4	0	-3	-4	-4	6	30
Interest Expense	0	0	-	-	0	0	0	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-4	-6	-4	-3	-3	-4	-4	0	30
Income Tax Expense	0	0	0	0	0	0	0	-1	-6	-
Net Income	-6	-4	-6	-4	-3	-3	-4	-4	0	30
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

PharmaCyte Biotech Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Net Income	0	1	23	-1	-3	11	-8	-7	0
Operating Cash Flow	0	0	0	-1	0	-1	-1	0	0
Investing Cash Flow	-5	-	-7	7	-	-	-	-3	5
Financing Cash Flow	-7	-10	-10	-10	-3	0	0	6	0
Change in Cash	-12	-11	-17	-11	-4	-1	-1	2	4

PharmaCyte Biotech Inc. Annual Cash Flow

All numbers in Millions USD

	Apr 2017	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Net Income	-4	-6	-4	-3	-3	-4	-4	0	30
Operating Cash Flow	-3	-5	-2	-2	-3	-4	-3	-2	-2
Investing Cash Flow	-	-	-	-	-	-	-	-5	-7
Financing Cash Flow	4	2	2	2	4	87	-13	-10	-25
Change in Cash	1	-2	0	0	1	83	-17	-17	-35

Global Institutional Holdings in PharmaCyte Biotech Inc.

Funds	Holdings
HRT FINANCIAL LLC	0.23%
IFP Advisors, LLC	0%
SIMPLEX TRADING, LLC	0.19%
Susquehanna International Group, LLP	0.41%
Bfsg, LLC	0%

See all

Insights on PharmaCyte Biotech Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, PMCB stock has moved up by 10.4%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 41.6%
NO EFFECT
Against Peers
In the last 3 years, PharmaCyte Biotech, Inc. Common Stock has experienced a drawdown of -72.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 51.4%

About PharmaCyte Biotech Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Organisation	PharmaCyte Biotech Inc.
Headquarters	3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169
Industry	Biotechnology
CEO	Mr. Joshua N. Silverman
E-voting on shares	Click here to vote

Key Management of PharmaCyte Biotech Inc.

Name	Title
Dr. Jose L. Iglesias M.D.	Consulting Chief Medical Officer
Dr. Hans-Peter Hammes M.D.	Member of Medical & Scientific Advisory Board and Consultant
Mr. Joshua N. Silverman	CEO. President & Executive Chairman
Mr. Carlos A. Trujillo CPA	Chief Financial Officer

FAQs

What is PharmaCyte Biotech Inc. share price today?

PharmaCyte Biotech Inc. share price today is $0.78 as on June 18, 2026 at 1:28 am IST at the close of the market. PharmaCyte Biotech Inc. share today touched a day high of $0.82 and a low of $0.78.

What is the 52 week high and 52 week low for PharmaCyte Biotech Inc. share?

PharmaCyte Biotech Inc. share touched a 52 week high of $1.51 on December 5, 2025 and a 52 week low of $0.63 on March 20, 2026. PharmaCyte Biotech Inc. stock price today i.e. June 18, 2026 at 1:28 am IST is closed at $0.78,which is 48.34% down from its 52 week high and 23.81% up from its 52 week low.

What is PharmaCyte Biotech Inc.'s market capitalisation today?

PharmaCyte Biotech Inc. market capitalisation is $0.00T as on June 18, 2026 at 1:28 am IST.

How to invest in PharmaCyte Biotech Inc. Stock (PMCB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for PharmaCyte Biotech Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PharmaCyte Biotech Inc. Shares that will get you 1.9231 shares as per PharmaCyte Biotech Inc. share price of $0.78 per share as on June 18, 2026 at 1:28 am IST.

What is the minimum amount required to buy PharmaCyte Biotech Inc. Stock (PMCB) from India?

Indian investors can start investing in PharmaCyte Biotech Inc. (PMCB) shares with as little as ₹94.5 or $1 (as of June 18, 2026 at 5:49 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in PharmaCyte Biotech Inc. stock (as per the Rupee-Dollar exchange rate as on June 18, 2026 at 5:49 am IST). Based on PharmaCyte Biotech Inc. share’s latest price of $0.78 as on June 18, 2026 at 1:28 am IST, you will get 12.8205 shares of PharmaCyte Biotech Inc.. Learn more about fractional shares .